Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most

If a drug maker tested an asthma treatment in children and found it significantly reduced attacks compared with a placebo, this would be considered good news, yes?

But what if the children enrolled in the clinical trial were almost entirely white, even though asthma disproportionately affects Black and Puerto Rican children?

This would dampen my enthusiasm, to say the least. And it would make me wonder why a company would fail to study enough of the children who are most in need.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In